#Hemoglobinopathy Testing Services Market share
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
The Tumblr office adopted Tommy, an 11-year-old Pomeranian.
Text
Adult Hemoglobinopathy Testing Market by Major Key Players,Competitive landscape and Forecast to 2030
On 2024-7-26 Global Info Research released【Global Adult Hemoglobinopathy Testing Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030】. This report includes an overview of the development of the Adult Hemoglobinopathy Testing industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adult Hemoglobinopathy Testing. According to our (Global Info Research) latest study, the global Adult Hemoglobinopathy Testing market size was valued at USD 186150 million in 2023 and is forecast to a readjusted size of USD 215380 million by 2030 with a CAGR of 2.1% during review period. The Adult Hemoglobinosis Test is a set of tests used to determine the presence and relative amount of abnormal forms of hemoglobin to screen or diagnose hemoglobinopathies and to adults. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. The Global Info Research report includes an overview of the development of the Adult Hemoglobinopathy Testing industry chain, the market status of Hospital (HPLC Detection, Hb Electrophoresis), Medical School (HPLC Detection, Hb Electrophoresis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Adult Hemoglobinopathy Testing. Regionally, the report analyzes the Adult Hemoglobinopathy Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Adult Hemoglobinopathy Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base. Market segment by Type： HPLC Detection、Hb Electrophoresis、Mass Spectrometry、Other Market segment by Application：Hospital、Medical School、Other Major players covered： Bio-Rad Laboratories、Thermo Fisher Scientific、PerkinElmer、Chromsystems Instruments & Chemicals GmbH、BioMedomics、CapitalBio Technology、Trinity Biotech、Streck
Market segment by region, regional analysis covers: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe), Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia),South America (Brazil, Argentina, Colombia, and Rest of South America),Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa). The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Adult Hemoglobinopathy Testing product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of Adult Hemoglobinopathy Testing, with price, sales, revenue and global market share of Adult Hemoglobinopathy Testing from 2019 to 2024. Chapter 3, the Adult Hemoglobinopathy Testing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Adult Hemoglobinopathy Testing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Adult Hemoglobinopathy Testing market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030. Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis. Chapter 13, the key raw materials and key suppliers, and industry chain of Adult Hemoglobinopathy Testing. Chapter 14 and 15, to describe Adult Hemoglobinopathy Testing sales channel, distributors, customers, research findings and conclusion.
Data Sources:
Via authorized organizations:customs statistics, industrial associations, relevant international societies, and academic publications etc.
Via trusted Internet sources.Such as industry news, publications on this industry, annual reports of public companies, Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), Trading Economics, News Network, Statista, Federal Reserve Economic Data, BIS Statistics, ICIS, Companies House Documentsm, investor presentations, SEC filings of companies, etc.
Via interviews. Our interviewees includes manufacturers, related companies, industry experts, distributors, business (sales) staff, directors, CEO, marketing executives, executives from related industries/organizations, customers and raw material suppliers to obtain the latest information on the primary market;
Via data exchange. We have been consulting in this industry for 16 years and have collaborations with the players in this field. Thus, we get access to (part of) their unpublished data, by exchanging with them the data we have.
From our partners.We have information agencies as partners and they are located worldwide, thus we get (or purchase) the latest data from them.
Via our long-term tracking and gathering of data from this industry.We have a database that contains history data regarding the market.
Global Info Research is a company that digs deep into global industry information to support enterprises with market strategies and in-depth market development analysis reports. We provides market information consulting services in the global region to support enterprise strategic planning and official information reporting, and focuses on customized research, management consulting, IPO consulting, industry chain research, database and top industry services. At the same time, Global Info Research is also a report publisher, a customer and an interest-based suppliers, and is trusted by more than 30,000 companies around the world. We will always carry out all aspects of our business with excellent expertise and experience.
0 notes
Text
Hemoglobinopathy Testing Services Market Projected To Experience Major Revenue Boost by 2024: Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb
"The latest Hemoglobinopathy Testing Services market research report offers a comprehensive analysis of the changing trends, supply-demand scenario, high growth opportunities, and future prospects of this business sphere."
AMR has added a new report titled Hemoglobinopathy Testing Services Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. Hemoglobinopathy Testing Services Market report objective is to describe market sizes of different segments and countries in recent years and to forecast to the coming seven years. Report provides strategy and advance marketing, market-entry, market extension, and other business plans by identifying the key market opportunities and prospects.
If you are an investor/shareholder in the Hemoglobinopathy Testing Services Market, the provided study will help you to understand the growth model of the Hemoglobinopathy Testing Services Industry after the impact of COVID-19.
Free Sample Report + All Related Graphs & Charts (Including COVID19 Impact Analysis) @ https://www.acquiremarketresearch.com/sample-request/372216/
The Hemoglobinopathy Testing Services Market is expected to have a highly positive outlook for the next five years 2021-2024 according to a recently released. The research report is committed to giving its readers an unbiased point of view of the global Hemoglobinopathy Testing Services market. Thus, along with statistics, it includes opinions and recommendation of market experts. This allows the readers to acquire a holistic view of the global market and the segments therein. The research report includes the study of the market segments on the basis of type, application, and region. This helps in identifying segment-specific drivers, restraints, threats, and opportunities.
Top Key market Vendors Profiled in this report are:
Novartis, AstraZeneca, Bluebird Bio, Bristol-Myers Squibb, Emmaus Medical, Acceleron Pharma, HemaQuest Pharmaceuticals, Eli Lilly and Company, Celgene Corporation
Hemoglobinopathy Testing Services Market Segmentation:
By Product Type
Hydroxyurea, Glutamine, Zynteglo, Luspatercept
By Application
Sickle Cell Diseases, Thalassemia
The key questions answered in this report:
What will be the Market Size and Growth Rate in the forecast year?
What are the Key Factors driving Hemoglobinopathy Testing Services Market?
What are the Risks and Challenges in front of the market?
Who are the Key Vendors in Hemoglobinopathy Testing Services Market?
What are the Trending Factors influencing the market shares?
What are the Key Outcomes of Porter’s five forces model?
Which are the Global Opportunities for Expanding the Hemoglobinopathy Testing Services Market?
Get 30% Discount on this Report @ https://www.acquiremarketresearch.com/discount-request/372216/
Geographically, the Global Hemoglobinopathy Testing Services Market is designed for the following Regional Markets:
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
📷
Hemoglobinopathy Testing Services Market Analysis Report Forecast 2021-2024
If you have any special requirements, please let us know and we will offer you the report as per your requirements.
Inquire or share your questions if any before the purchasing this report : http://www.acquiremarketresearch.com/enquire-before/372216
Table of Contents:
Global Hemoglobinopathy Testing Services Market Research Report 2021 – 2024
Chapter 1 Hemoglobinopathy Testing Services Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Global Hemoglobinopathy Testing Services Market Forecast
Read More Industry Reports @ https://marketstrategyideas.wordpress.com/
Contact Us:
Phone: +1-800-663-5579
Email: [email protected]
Address: 555 Madison Avenue, 5th Floor, Manhattan, New York, 10022 USA
#Hemoglobinopathy Testing Services Market#Hemoglobinopathy Testing Services Market analysis#Hemoglobinopathy Testing Services Market forecast#Hemoglobinopathy Testing Services Market scope#Hemoglobinopathy Testing Services Market share#Hemoglobinopathy Testing Services Market size#Hemoglobinopathy Testing Services Market trends#Hemoglobinopathy Testing Services market report 2021#Hemoglobinopathy Testing Services market forecast to 2024#Acquire Market Research#Hemoglobinopathy Testing Services market COVID Impact#APAC Hemoglobinopathy Testing Services market#europe Hemoglobinopathy Testing Services market#us Hemoglobinopathy Testing Services market
0 notes
Text
Hematology Analyzer Market Growth (Status and Outlook) 2020-2026
Market Analysis and Insights: Hematology Analyzer Market
Hematology Analyzer Market By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services), Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers), End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2019 to 2026. The imminent market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026. The growth of the market can be attributed to the rising blood donation awareness among people.
Request Sample is Available @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzer-market
Market Definition: Global Hematology Analyzer Market
Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers. This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.
Market Drivers
Rising cases of blood disorders is boosting the market growth
Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
Integration of hematology analyzers with flow cytometry will act as a driver for the market growth
Market Restraints
Safety alerts and product recalls is hampering the market growth
Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period
Segmentation: Global Hematology Analyzer Market
By Product and Services
Instruments
Reagents & Consumables
Services
Instruments
Reagents & Consumables
Services
Instruments
Reagents & Consumables
Services
For Further Detailed insights and ‘Any Query About this report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzer-market
By Price Range
High-End Hematology Analyzers
Mid-Range Hematology Analyzers
Low-End Hematology Analyzers
By End User
Hospital Laboratories
Commercial Service Providers
Government Reference Laboratories
Research and Academic Institutes
By Geography
U.S.
Canada
Mexico
Brazil
Rest of South America
Germany
Italy
U.K.
France
Spain
Netherlands
Belgium
Switzerland
Turkey
Russia
Rest of Europe
Japan
China
India
South Korea
Australia
Indonesia
Malaysia
Singapore
Thailand
Philippines
Rest of Asia-Pacific
South Africa
Rest of Middle East & Africa
Key Developments in the Market:
In November 2018, PixCell Medical Technologies Ltd. got FDA 510(k) clearance for its product PixCellm Medical’s HemoScreen. This analyzer is use to perform a complete blood count at the point of care. With this clearance the company will enhance its product portfolio in the market
In January 2018, Beckman Coulter announced approval of Health Canada's Medical Device License for DxH 900 hematology analyzer and novel early sepsis indicator. The product will help in native-state cellular characterization for early sepsis detection. This innovation will lead Beckman Coulter advancement in clinical diagnostics
Competitive Analysis:
Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors:
Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.
Request for complete Toc @ https://www.databridgemarketresearch.com/toc/?dbmr=global-hematology-analyzer-market
Research Methodology: Global Hematology Analyzer Market
Data assemblage and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.
Reasons to Purchase this Report
Current and future of global hematology analyzer market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Read other Report
Asia-Pacific Anti-Nuclear Antibody Test Market
Asia-Pacific Rx Dermatology Topical Drug Delivery Market
Europe Anticoagulation Therapy Market
Europe Dry Eye Syndrome Treatment Market
Ameloblastic Carcinoma Market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact: Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Hematology Diagnostics Market Expected to Gain Growth in the Forecast Period of 2020 to 2027
Hematology Diagnostics Market – Overview
The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better. The market is set to profit from the positive CAGR in the market during the forecast period.
The increased prevalence of blood-related disorders is motivating the expansion of the hematology diagnostics market. Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics. The increased involvement of genetic diseases in blood-related ailments is projected to fuel the development of the hematology diagnostic market in the coming years.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/6262
Segmental Analysis
The segmental analysis of the hematology diagnostics market is segmented on the basis of tests, product type, and end-user. By product type, the hematology diagnostics market is segmented into flow cytometers, and consumables. The tests segment is additionally segmented into leukemia/lymphoma phenotyping, hemoglobinopathy, anemia, hematology pathophysiology, complete blood count (CBC) and others. Based on end-users, the market is segmented into ambulatory surgical centers, diagnostic laboratories, hospitals and clinics, academic institutes and others.
Detailed Regional Analysis
The regional analysis of the hematology diagnostics market share states that the North American region dominates the market due to the mounting incidence of blood diseases. The presence of the primary market players within the region is influencing the market growth. Factors such as growing healthcare expenditure, technological improvements within the population are driving the market development in this region. The European region is the subsequent market contender in the global hematology diagnostics market due to the growing hematology research within this region. The growing hematology research and government initiatives within this region are influencing the development of the hematology diagnostic market in this region.
The Asia Pacific region was recognized as the quickest rising region for the hematology diagnostics market globally in 2017. The market is projected to observe considerable development due to the intensifying commonness of blood disorders and genetic diseases. The predisposition of individuals in the region to genetic disorders due to marriages to blood relatives or marrying within the same community, ethnicity, caste, etc. The Middle Eastern and African region controls the smallest stake in the hematology diagnostics market globally owing to the incidence of strict government policies and deprived economies. Though, the market is projected to observe growth owing to increased investments by private market players in the Middle East. Moreover, the increasing incidence of genetic blood disorders and expanding government initiatives to develop the healthcare sector within the region is expected to contribute to the market’s growth.
Competitive Analysis
The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors. Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.
The central contenders in the hematology diagnostics market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/hematology-diagnostics-market-6262
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Hematology Analyzer Market Research Report with Outlook, Strategies
Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2020 to 2026. Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers.
Key Market Competitors:
Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzer-market
This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.
Segmentation: Global Hematology Analyzer Market
· By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services)
· By Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers)
· By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes)
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Competitive Analysis:
Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Drivers
· Rising cases of blood disorders is boosting the market growth
· Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
· Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
· Integration of hematology analyzers with flow cytometry will act as a driver for the market growth
Market Restraints
· Safety alerts and product recalls is hampering the market growth
· Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
· Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period
For More Inquiry Contact us at: @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzer-market
Reasons to Purchase this Report
· Current and future of global hematology analyzer market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
Related Reports:
Ebola virus infection drug
Gorlin Syndrome Market
#Hematology Analyzer Market#Hematology Analyzer#Hematology Analyzer Market Trends#Hematology Analyzer Market Industry#Hematology Analyzer Market News
0 notes
Link
0 notes
Text
Hematology Analyzer Market Research Report with Outlook, Strategies, Challenges, Geography Trends
Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2020 to 2026. Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers.
Key Market Competitors:
Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzer-market
This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.
Segmentation: Global Hematology Analyzer Market
· By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services)
· By Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers)
· By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes)
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Competitive Analysis:
Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Drivers
· Rising cases of blood disorders is boosting the market growth
· Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
· Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
· Integration of hematology analyzers with flow cytometry will act as a driver for the market growth
Market Restraints
· Safety alerts and product recalls is hampering the market growth
· Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
· Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period
For More Inquiry Contact us at: @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzer-market
Reasons to Purchase this Report
· Current and future of global hematology analyzer market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
Related Reports:
Ebola virus infection drug
Gorlin Syndrome Market
#Hematology Analyzer Market#Hematology Analyzer#Hematology Analyzer Market Trends#Hematology Analyzer Market Industry#Hematology Analyzer Market News#Hematology Analyzer Market Research
0 notes
Text
Hematology Diagnostics Market Overview, Applications, Investment, Price and Profit | Forecast to 2023
Hematology Diagnostics Market Research Report, by Product Type (Hematology Analyzer, Flow Cytometer, Consumable), Tests (Hemoglobinopathy, Leukemia Phenotyping), End-User (Hospitals & Clinics, Diagnostic Laboratories) – Global Forecast Till 2023
Hematology Diagnostics Market Detailed Regional Analysis: The regional analysis of the hematology diagnostics market states that the North American region dominates the market due to the mounting incidence of blood diseases. The presence of the primary market players within the region is influencing the market growth. Factors such as growing healthcare expenditure, technological improvements within the population are driving the market development in this region. The European region is the subsequent market contender in the global hematology diagnostics market due to the growing hematology research within this region. The growing hematology research and government initiatives within this region are influencing the development of the hematology diagnostic market in this region.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6262
The Asia Pacific region was recognized as the quickest rising region for the hematology diagnostics market globally in 2017. The market is projected to observe considerable development due to the intensifying commonness of blood disorders and genetic diseases. The predisposition of individuals in the region to genetic disorders due to marriages to blood relatives or marrying within the same community, ethnicity, caste, etc. The Middle Eastern and African region controls the smallest stake in the hematology diagnostics market globally owing to the incidence of strict government policies and deprived economies. Though, the market is projected to observe growth owing to increased investments by private market players in the Middle East. Moreover, the increasing incidence of genetic blood disorders and expanding government initiatives to develop the healthcare sector within the region is expected to contribute to the market’s growth.
Hematology Diagnostics Market Segmental Analysis: The segmental analysis of the hematology diagnostics market is segmented on the basis of tests, product type, and end-user. By product type, the hematology diagnostics market is segmented into flow cytometers, and consumables. The tests segment is additionally segmented into leukemia/lymphoma phenotyping, hemoglobinopathy, anemia, hematology pathophysiology, complete blood count (CBC) and others. Based on end-users, the market is segmented into ambulatory surgical centers, diagnostic laboratories, hospitals and clinics, academic institutes and others.
Hematology Diagnostics Market Competitive Analysis: The growth of the market is moving in a favorable direction due to new product launches or rising gross revenue of the players in the market. Significant reductions in administrative costs are inducing further expansion of the market. The vertical additions and product tactics of the market are boosting the potential of the market players. The development of a robust value chain is further motivating the development of the market. The strategic goals intended for the market are reinforced due to favorable product differentiation carried out by market competitors. Increased adaptability of market players to new market trends and customers inclinations are lifting the growth curve of the market and will continue do so in the forecast period. The successful implementation of strategies is expected to motivate the market in the coming years.
The central contenders in the hematology diagnostic market globally are Ortho Clinical Diagnostics (US), Danaher (US), Siemens (Germany), Boule Diagnostics (Sweden), HORIBA (Japan), Abbott Laboratories (US), EKF Diagnostics (UK), Bio-Rad Laboratories (US), BioSystems (Spain), Sysmex (Japan), Diatron (Hungary), Nihon Kohden (Japan), Drew Scientific (US), Mindray (China), and Roche (Switzerland), and other.
Hematology Diagnostics Market Overview: The renewed emphasis on health and wellness has prompted an increased focus on blood-related disorders as well. The market is set to profit from the positive CAGR in the hematology diagnostic market during the forecast period. Market reports connected with the healthcare industry have been presented by Market Research Future which makes reports on other industry verticals that aims to analyze the current market scenarios better.
Browse Detailed TOC at: https://www.marketresearchfuture.com/reports/hematology-diagnostics-market-6262
The increased prevalence of blood-related disorders is motivating the expansion of the hematology diagnostics market. Moreover, the development in the detection and diagnostic methods has improved the growth of the market for hematology diagnostics. The increased involvement of genetic diseases in blood-related ailments is projected to fuel the development of the hematology diagnostic market in the coming years.
Brows More Healthcare Related Research Reports at:
Cheilectomy Market Research Report | MRFR
Heart Rate Monitor Market Size Analysis, Share | Application, 2023
Global Artificial Eye Market Research Report- Forecast To 2023 | MRFR
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]
0 notes
Text
Hematology Analyzer Market Strategic Insights and key Business Influencing Factors
Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2020 to 2026. Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers.
Key Market Competitors:
Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzer-market
This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.
Segmentation: Global Hematology Analyzer Market
· By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services)
· By Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers)
· By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes)
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Competitive Analysis:
Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Drivers
· Rising cases of blood disorders is boosting the market growth
· Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
· Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
· Integration of hematology analyzers with flow cytometry will act as a driver for the market growth
Market Restraints
· Safety alerts and product recalls is hampering the market growth
· Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
· Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period
For More Inquiry Contact us at: @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzer-market
Reasons to Purchase this Report
· Current and future of global hematology analyzer market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
Related Reports:
Ebola virus infection drug
Gorlin Syndrome Market
#Hematology Analyzer Market#Hematology Analyzer#Hematology Analyzer Market Trends#Hematology Analyzer Market Industry#Hematology Analyzer Market News#Hematology Analyzer Market Research
0 notes
Text
Hematology Analyzer Market Size Global Gathering and Future Outlook 2020 to 2026
Global hematology analyzer market estimated to rise at a substantial CAGR of 6.6% in the forecast period of 2020 to 2026. Hematology analyzers are medical devices used to run tests on blood samples in which counting of WBC is performed by Hematology analyzers.
This tool is commonly used in clinical labs to characterize blood cell numbers and types. Hematology analyzers are made of several analytical tools, with different preparative procedure. It also controls the plasma level for drugs. These analyzers help in number of diseases, such as anemia, infections and cancer among others.
Get Exclusive Sample Report: @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hematology-analyzer-market
Key Market Competitors:
Some of the major companies functioning in global hematology analyzer market are Abbott, Beckman Coulter Inc, HORIBA Ltd, Siemens, Sysmex, NIHON KOHDEN CORPORATION, Bio-Rad Laboratories inc, Johnson & Johnson, Thermo Fisher Scientific,BD, F. Hoffmann-La Roche Ltd, Boule Diagnostics AB., Danaher, Diatron, Erba Diagnostics, Inc., VirtualExpo, Drucker Diagnostics, EKF DIAGNOSTICS HOLDINGS PLC, Ortho Clinical Diagnostics, Shenzhen Mindray Bio-Medical Electronics Co, Ltd and Biosystems S.A among others.
Segmentation: Global Hematology Analyzer Market
· By Product and Services (Hematology Products & Services, Hemostasis Products & Services, Immunohematology Products & Services)
· By Price Range (High-End Hematology Analyzers, Mid-Range Hematology Analyzers, Low-End Hematology Analyzers)
· By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes)
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa)
Competitive Analysis:
Global hematology analyzer market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of hematology analyzer market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Drivers
· Rising cases of blood disorders is boosting the market growth
· Innovations in several field including pharmacogenomics, genetic therapies, hemoglobinopathies, stem cell research and proteomics will propel the growth of the market
· Adoption of automated hematology instruments amalgamate with rising preferences of high sensitivity hematology testing is also fueling the market in the forecast period
· Integration of hematology analyzers with flow cytometry will act as a driver for the market growth
Market Restraints
· Safety alerts and product recalls is hampering the market growth
· Slow adoption of advanced hematology instruments in emerging countries may hinder the growth of the market
· Stringent regulatory policies for hematology analyzers will restraint the market in the forecast period
For More Inquiry Contact us at: @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hematology-analyzer-market
Reasons to Purchase this Report
· Current and future of global hematology analyzer market outlook in the developed and emerging markets
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
· All segmentation provided above in this report is represented at country level
· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
Related Reports:
Ebola virus infection drug
Gorlin Syndrome Market
#Hematology Analyzer Market#Hematology Analyzer#Hematology Analyzer Market Trends#Hematology Analyzer Market Industry#Hematology Analyzer Market News#Hematology Analyzer Market Research
0 notes
Text
Hemoglobinopathies Market to Reap Over US$ 5.31 Billion in Revenues by End of 2026
The detailed market intelligence report on the Hemoglobinopathies market applies the best of both primary and secondary research to weighs upon the competitive landscape and the prominent market players expected to dominate the Hemoglobinopathies market for the forecast period, 2019 - 2026. The study not only scans through the company profile of the major vendors but also analyses their winning strategies to give business owners, stakeholders and field marketing personnel a competitive edge over others operating in the same space. A detailed evaluation of the major events such as acquisition and mergers, collaborations, product launches, new entrants, and technology advancements offer a complete overview of what the future of the Hemoglobinopathies market will be like in the years to come.
Market Size – USD 5.31 Billion in 2018, Market Growth - CAGR of 10.2%, Market Trends – Product launches and research for advanced Hemoglobinopathies Market
Request For Free PDF Sample Of This Research Report At: https://www.reportsanddata.com/sample-enquiry-form/2165
Key participants include Alnylam Pharmaceuticals, Gamida Cell, Biogen Idec, AcceleronPharma, Sangamo BioSciences, Anthera Pharmaceuticals, Global Blood Therapeutics, Geetix Pharmaceuticals, Mast Therapeutics, Prolong Pharmaceuticals, Emmaus Medical, Celgene Corporation, Invenux, Optinova Ab, and HemaQuest Pharmaceuticals
Scope of the Report:
Based on the in-depth analysis the research also brings to light major facts pertaining to the vital aspects such as market share, size, and growth rate. Deep dive into other aspects including the investment feasibility, demand and supply, import and export status, supply chain management and growth prospects narrates a lot about what the business environment will be like for the forecast period,2019 - 2026. All the vital statistics in the report are explained with the help of resources such as tables, charts, and info graphics.
Various research techniques are applied to produce data on competitors’ strategies; past, present and future sales and purchasing trends. Business owners aiming to inspect the present consumer base and reaching the target audience will be able to leverage the demographic details derived from different regions, to infer dynamic market shifts. Perspectives on different disruptive forces that are believed to have a transformative influence on the future sales make the document valuable. Insights on where the Hemoglobinopathies market should be heading during the forecast years from 2019 to 2026. The report also sheds light on how major vendors are transforming the business today.
Segments covered in the report:
For the purpose of this report, Reports and Data has segmented the Hemoglobinopathies market on the basis of type, Therapy Type, Test type, and region:
Type (Revenue, USD Million; 2016–2026)
Thalassemia
Sickle Cell Disease
Other Hb Variants Diseases
Therapy Type (Revenue, USD Million; 2016–2026)
Blood transfusion
Iron chelation therapy
Bone marrow transplant
Others
View Exhaustive Market Research Press Release@ https://www.reportsanddata.com/press-release/global-hemoglobinopathies-market
Test Type (Revenue, USD Million; 2016–2026)
Red blood cell (RBC) count test
Genetic testing
Liquid chromatography (HPLC) test
Hemoglobin isoelectric (Hb IEF) focusing
Hemoglobin electrophoresis (Hb ELP) test
Hemoglobin solubility test.
Regional Outlook (Revenue in USD Million; 2016–2026)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Rest of MEA
The study predicts what the future Hemoglobinopathies market can be expected to witness. The research also familiarizes product owners with immediate threats in the market, buyer’s requirements, and the effective business strategies implemented by prominent industry players. The report aims to help both existing companies and new entrants not only prepare against the disruption but also see opportunities. In-depth examination of market trends, including the assessment of government bodies, financial organization, and other regulatory bodies. Starting with a macroeconomic outlook, the study performs a detailed examination of the sub-categories of the industry and the trends that have an impact on the business.
Browse the comprehensive TOC and data tables @ https://www.reportsanddata.com/report-detail/hemoglobinopathies-market
The research provides answers to the following key questions:
What will be the marketing and pricing strategies adopted by prominent vendors operating in the Hemoglobinopathies market for the forecast years from 2019 to 2026?
What are the new uses for the existing products or services and how have they contributed towards increasing the demand for products or services?
What are the general conditions prevailing and influencing the business environment of the Hemoglobinopathies market?
Who are the key manufacturers venturing into new geographies to establish a lucrative market their products and services?
What will be the dynamics of the demand and supply and the requirements of the distribution channel across the globe in the near future?
What will be the market share of the Hemoglobinopathies industry over the considered time periods?
About Us: Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Contact Us: John Watson Head of Business Development Direct Line: +1-212-710-1370 E-mail: [email protected] Reports and Data | Web: www.reportsanddata.com
0 notes
Text
Recent Trends In Hemoglobinopathies Market By 2026
The global hemoglobinopathies market size is expected to reach USD 12.6 billion by 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 10.2% during the forecast period.
Rising prevalence of hemoglobin disorders such as Sickle Cell Disease (SCD), thalassemia, Hb C, and Hb E is estimated to be a high impact rendering driver for the market. According to the World Health Organization (WHO), hemoglobin disorders are endemic in over 60% of 229 countries affecting over 70% of births. It is also reported that minimum 5% of the world population are carriers of significant hemoglobin variation.
Prevalence of hemoglobinopathies is high in low-income countries from regions, such as Sub-Saharan region and South-east Asia. 85% of the affected population in U.S. and Europe has ancestral base in these regions.
Governments are collaborating with local institutes to undertake awareness programs for curbing the effect of hemoglobinopathies-related mortality rate. For instance, Sickle Cell Disease Coalition (SCDC) was founded by The American Society of Hematology (ASH) in 2016 to promote awareness for the condition and enhance outcomes for individuals.
Insufficient healthcare infrastructure and low levels of disease diagnosis and treatments are some of the key factors contributing to the increase in target population in low-income regions such as South-east Asia, Mediterranean basin, and Africa.
North America led the overall hemoglobinopathies market in terms of revenue in 2018. Growing prevalence of blood disorders, favorable government programs, and high level of awareness among healthcare professionals and patients for hemoglobinopathies-related genetic testing, are the factors attributed to the growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to the presence of high unmet clinical needs, improving healthcare infrastructure, and rising economic levels. Moreover, introduction of low-cost diagnostic alternatives for hemoglobinopathies is likely to further boost the growth.
To request a sample copy or view summary of this report, click the link below: https://www.grandviewresearch.com/industry-analysis/hemoglobinopathies-market
Further key findings from the report suggest:
SCD segment held the largest market share in 2018 owing to rising prevalence of sickle cell disease and presence of strong product pipeline such as LentiGlobin
Genetic testing for diagnosis of sickle cell disorders is expected to witness lucrative growth over the forecast period. Increasing awareness coupled with rising government programs is anticipated to enhance the usage rates for diagnostic tests pertaining to SCD
Pre-implant genetic diagnosis is estimated to witness lucrative CAGR of over 8.0% during the forecast period owing to rising awareness levels among the population and increasing healthcare expenditure
Blood transfusion was the largest therapy segment for hemoglobinopathies, owing to high acceptance of this treatment option and significant success rate
Key market players include Gamida Cell; Alnylam Pharmaceuticals; Sanofi; Sangamo Therapeutics Inc.; Global Blood Therapeutics; bluebird bio Inc.; Emmaus Life Sciences Inc.; Prolong Pharmaceuticals; and Celgene Corporation
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: [email protected] For More Information: www.grandviewresearch.com
0 notes
Text
Hemoglobinopathies Market Is Expected To Reach USD 8.8 Billion By 2022: By Grand View Research, Inc.
Global hemoglobinopathies market is expected to reach over USD 8.82 billion by 2022 according to a new report by Grand View Research Inc. Rising prevalence of hemoglobin disorders such as sickle cell anemia, thalassemia, Hb C, and Hb E is estimated to be the high impact rendering drivers of the market. According to the WHO, hemoglobin disorders are endemic in over 60% of 229 countries affecting over 70% of births. It is also reported that minimum 5% of the world population are carriers of significant variation.
Prevalence of hemoglobinopathies is high in low-income countries such as Sub Saharan region and South East Asia. 85% of the affected population in the U.S. and Europe has ancestral base in these regions.
Governments are collaborating with local institutes to undertake awareness programs for curbing the effect of hemoglobinopathies-related mortality rate. For instance, Thalassemia Data Collection Project and Registry and Surveillance System for Hemoglobinopathies (RuSH) projects were started in 2010 by the Centers for Disease Control and Prevention (CDC).
Low level of hygiene, insufficient healthcare infrastructure, and lesser awareness levels are some key factors attributing to increase in base of target population in low-income regions such as South East Asia, Mediterranean basin, and Africa.
Browse full research report on Hemoglobinopathies Market: http://www.grandviewresearch.com/industry-analysis/hemoglobinopathies-market
Further key findings from the study suggest:
The market for Sickle Cell Disease (SCD) was the largest with revenue valued at over USD 2,290.0 million in 2014. Rising prevalence of hemoglobinopathies and presence of strong product pipeline for sickle cell anemia such as HQK-1001 and Luspatercept are growth promoting factors of this market.
Genetic testing for diagnosis of sickle cell disorders is expected to witness lucrative growth over the forecast period. It is estimated to grow at a CAGR of around 7.0%. Increasing awareness levels among people coupled with government programs such as the National Sickle Cell Disease Control Program conducted by the WHO in Africa are anticipated to enhance the usage rates for diagnostic tests pertaining to SCD.
Hydroxyurea was one of the dominating segments of the SCD therapy market owing to the presence of the FDA-approved drugs such as Droxia and Hydrea by Bristol Myers Squib. SCD. Thalassemia market holds an extensive product portfolio in pipeline and their expected commercialization is anticipated to drive market growth. For instance, The Ellis Lab is developing a gene therapy for SCD in collaboration with Dr. Victor Garcia
Blood tests including cell blood count and iron studies are the widely used techniques for diagnosis of thalassemia. On the other hand, pre-implant genetic testing is estimated to grow at lucrative growth rate over 8.5% in the next six years owing to rising base of health conscious population and increasing healthcare expenditure.
The market for blood transfusion was the largest with revenues valued at over USD 1,408.0 million in therapeutic segment owing to, high acceptance level of this treatment option and significant success rate. It is estimated that around 85% of infants below five years suffering from thalassemia die due to insufficient blood transfusion.
North America dominated the overall hemoglobinopathies market in terms of revenue in 2014 at over USD 1,212.0 million. Growing prevalence of blood disorders, favorable government programs, and high level of awareness among healthcare professionals and patients for hemoglobinopathies-related genetic testing are factors attributing to the major share of this market.
Asia Pacific market is expected to witness lucrative growth over the forecast period with a CAGR of over 10% owing to the presence of high unmet clinical needs, improving healthcare infrastructure, and rising economic levels. Moreover, introduction of low-cost diagnostic alternatives will enhance adoption rates for hemoglobinopathies diagnostics market.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the hemoglobinopathies market on the basis of type, diagnostics, and therapeutics:
Global Hemoglobinopathies Therapy Outlook (Revenue, USD Million), 2012 – 2022
Alpha thalassemia
Beta thalassemia
Global Hemoglobinopathies Diagnosis Outlook (Revenue, USD Million), 2012 – 2022
Alpha thalassemia
Beta thalassemia
Sickle cell disease
Hemoglobin variants diseases
Hemoglobinopathies Regional Outlook (Revenue, USD Million), 2012 – 2022
U.S.
Canada
Germany
UK
Japan
China
Brazil
Mexico
South Africa
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-hemoglobinopathies-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: http://www.grandviewresearch.com
#Hemoglobinopathies Market#Hemoglobinopathies Market Size#Hemoglobinopathies Market Analysis#Hemoglobinopathies Market Trends#Hemoglobinopathies Market Share
0 notes
Link
0 notes
Link
0 notes
Link
0 notes